Wedbush Reaffirms Neutral Rating for Intellia Therapeutics (NASDAQ:NTLA)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Crispr Therapeutics: Now Is The Time To Buy (NASDAQ:CRSP)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.
Intellia Therapeutics (NASDAQ:NTLA) Reaches New 1-Year Low at $19 77
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.